Safety considerations for patients with epilepsy taking antiepileptic drugs alongside caffeine or other methylxanthine derivatives

Bibliography

• Bernstein GA, Carroll ME, Thuras P, et al. Caffeine dependence in teenagers. Drug Alcohol Depend 2002;66:1-6
   PubMed Web of Science ®Google Scholar
• Gilbert RM, Marshman JA, Schwieder M, Berg R. Caffeine content of beverages as consumed. Can Med Assoc J 1976;114:205-7
   PubMed Web of Science ®Google Scholar
• Jankiewicz K, Chroscinska-Krawczyk M, Blaszczyk B, Czuczwar SJ. Caffeine and antiepileptic drugs: experimental and clinical data. Przegl Lek 2007;64:965-7; in Polish
   PubMedGoogle Scholar
• Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanism of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992;17:139-70
   PubMed Web of Science ®Google Scholar
• Chu NS. Caffeine-and aminophylline-induced seizures. Epilepsia 1981;22:85-94
   PubMed Web of Science ®Google Scholar
• Cutrufo C, Bortot L, Giachetti A, Manzini S. Different effects of various xanthines on pentylenetetrazole-induced seizures in rats: an EEG and behavioural study. Eur J Pharmacol 1992;222:1-6
   PubMedGoogle Scholar
• Czuczwar SJ, Gasior M, Janusz W, et al. Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia 1990;31:318-23
   PubMed Web of Science ®Google Scholar
• Czuczwar SJ, Janusz W, Wamil A, Kleinrok Z. Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol 1987;144:309-15
   PubMed Web of Science ®Google Scholar
• Schwabe U, Ukena D, Lohse MJ. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 1985;330:212-21
   PubMed Web of Science ®Google Scholar
• Czuczwar SJ, Kleinrok Z. Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients. Pharmacol Res 1990;22:661-5
   PubMed Web of Science ®Google Scholar
• Czapiński P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 2005;5:1-9
   Google Scholar
• Svennigsson P, Hall M, Sedval G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 1997;27:322-35
   PubMed Web of Science ®Google Scholar
• Kumar V, Sharma A. Adenosine on endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol 2009;29:751-4
   Google Scholar
• Londos C, Cooper D, Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 1980;77:2551-4
   PubMed Web of Science ®Google Scholar
• Daly JW, Butts-Lamb P, Padgett W. Subclasses of adenosine receptors in the central nervous system: interactions with caffeine and related methylxanthines. Cell Mol Neurobiol 1983. 3:69-80
   Google Scholar
• Sebastiao AM, Ribeiro JA. Adenosine A2 receptor mediated excitatory action on the nervous system. Prog Neurobiol 1996;48:167-89
   PubMed Web of Science ®Google Scholar
• Fredholm BB, Lizerman AP, Jacobsen KA, et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;51:527-52
   Google Scholar
• Boison D. Methylxanthines, seizures, and excitotoxicity. Handb Exp Pharmacol 2011;200:251-66
   PubMedGoogle Scholar
• Borowicz KK, Luszczki J, Czuczwar SJ. 2-Chloroadenosine, a preferential agonist of A1 adenosine receptors, enhances the anticonvulsant activity of carbamazepine and clonazepam. Eur Neuropsychopharmacl 2002;12:173-9
   PubMed Web of Science ®Google Scholar
• Rezvani ME, Mirnajafi-Zadeh J, Fathollahi Y, Palizyan MR. Anticonvulsant effect of A1 but not of A2A adenosine receptors of piriform cortex in amygdala-kindled rats. Can J Physiol Pharmacol 2007;85:606-12
   PubMed Web of Science ®Google Scholar
• Dingledine R, McBain C, McNamara JO. Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 1990;11:334-8
   PubMed Web of Science ®Google Scholar
• Zeraati M, Mirnajafi-Zadeh J, Fathollahi Y, et al. Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects of piriform cortex kindled seizures in rats. Seizure 2006;15:41-8
   PubMed Web of Science ®Google Scholar
• Brown RA, Spina D, Page CP. Adenosine receptors and asthma. Br J Pharmacol 2008;153:446-56
   PubMed Web of Science ®Google Scholar
• Von Lubitz DK, Carter MF, Deutsch SI, et al. The effects of adenosine A3 receptors stimulation on seizures in mice. Eur J Pharmacol 1995;275:23-9
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Kleinrok Z, Czuczwar SJ. N6-2-(4-aminophenyl)ethyl-adenosine enhances the anticonvulsive activity of antiepileptic drugs. Eur J Pharmacol 1997;327:125-33
   PubMed Web of Science ®Google Scholar
• Koryntova H, Kubova H, Tutka P, Mares P. Changes of cortical epileptic afterdischarges under the influence of convulsant drugs. Brain Res Bull 2002;58:49-51
   PubMed Web of Science ®Google Scholar
• Tchekalarova J, Kubova H, Mares P. Postnatal caffeine treatment affects differently two pentylenetetrazol seizure models in rats. Seizure 2009;18:463-9
   PubMed Web of Science ®Google Scholar
• Moraidis J, Bingman D. Epileptogenic actions of xanthines in relation to their activities for adenosine A1 receptors in CA3 neurons of hippocampal slices (guinea pig). Brain Res 1994;640:140-5
   PubMed Web of Science ®Google Scholar
• Gasior M, Borowicz KK, Buszewicz G, et al. Anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice during chronic treatment with caffeine and caffeine discontinuation. Epilepsia 1996;37:262-8
   PubMed Web of Science ®Google Scholar
• Gasior M, Borowicz KK, Kleinrok Z, Czuczwar SJ. Chronic caffeine and the anticonvulsant potency of antiepileptic drugs against maximal electroshock. Pharmacol Biochem Behav 1996;54:639-44
   PubMed Web of Science ®Google Scholar
• Luszczki JJ, Zuchora B, Sawicka KM, et al. Acute exposure to caffeine decreases the anticonvulsant action of ethosuximide, but not clonazepam, phenobarbital and valproate against pentetrazole-induced seizures in mice. Pharmacol Rep 2006;58:652-9
   PubMed Web of Science ®Google Scholar
• Chrościńska M, Jargiełło M, Czuczwar SJ. Influence of caffeine on the protective action of some convenional and novel antiepileptic drugs - an experimental evidence. Pharmacol Rep 2007;59:118
   Web of Science ®Google Scholar
• Gasior M, Swiader M, Przybylko M, et al. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice. Eur J Pharmacol 1998;352:207-14
   PubMed Web of Science ®Google Scholar
• Chroscinska-Krawczyk M, Ratnaraj N, Patsalos PN, Czuczwar SJ. Effect of caffeine on the anticonvulsant effects of oxcarbazepine, lamotrigine, and tiagabine in a mouse model of generalized tonic-clonic seizures. Pharmacol Rep 2009;61:819-26
   PubMed Web of Science ®Google Scholar
• Kulkarni C, Joseph T, David J. Influence of adenosine receptor antagonists, aminophylline and caffeine, on seizure protective ability of antiepileptic drugs in rats. Indian J Exp Biol 1991;29:751-4
   PubMedGoogle Scholar
• Kaufman K, Sachdeo R. Caffeinated beverages and decreased seizure control. Seizure 2003;12:519-21
   PubMed Web of Science ®Google Scholar
• Bonhilha L, Li M. Heavy coffe drinking and epilepsy. Seizure 2004;13:284-5
   PubMed Web of Science ®Google Scholar
• Czuczwar SJ, Janusz W, Szczepanik B, Kleinrok Z. Influence of CGS. 15943A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock- induced seizures in mice. J Neural Transm Gen Sect 1991;86:127-34
   PubMed Web of Science ®Google Scholar
• Margineau DG, Klitgaard H. Caffeine-induced epileptiform field potentials in rat hippocampal slices: a pharmacological characterization. Neuropharmacology 2004;47:926-34
   PubMed Web of Science ®Google Scholar
• Neering JR, McBurney RN. Role for microsomal Ca storage in mammalian neurons? Nature 1984;309:158-60
   PubMed Web of Science ®Google Scholar
• Butanda-Ochoa A, Höjer G, Morales –Tlalpan V, Diaz-Muňoz M. Recognition and activation of ryanodine receptors by purines. Curr Med Chem 2006;13:647-57
   PubMed Web of Science ®Google Scholar
• Daly JW. Alkylxanthines as research tools. J Auton Nerv Syst 2000;81:44-52
   PubMedGoogle Scholar
• Lason W, Dudra-Jastrzebska M, Rejdak K, Czuczwar SJ. Basic mechanism of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update. Pharmacol Rep 2011;63:271-92
   PubMed Web of Science ®Google Scholar
• Perucca E. An introduction to antiepileptic drugs. Epilepsia 2005;46(Suppl 4):31-7
   PubMedGoogle Scholar
• De Sarro A, Grasso S, Zappala M, et al. Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats. Naunyn Schmiedebergs Arch Pharmacol 1997;356:48-55
   PubMed Web of Science ®Google Scholar
• Bierman CW, Williams PV. Therapeutic monitoring of theophylline. Rational and current status. Clin Pharmacokinet 1989;17:377-81
   PubMed Web of Science ®Google Scholar
• Yarnell PR, Chu NS. Focal seizures and aminophylline. Neurology 1975;25:819-22
   PubMed Web of Science ®Google Scholar
• Zwillich CW, Sutton FD, Neff TA, et al. Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann Intern Med 1975;82:784-7
   PubMed Web of Science ®Google Scholar
• Czuczwar SJ, Ikonomidou C, Kleinrok Z, et al. Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 1986;27:204-8
   PubMed Web of Science ®Google Scholar
• Borowicz K, Kozicka M, Kleinrok Z, et al. Influence of aminophylline and 8-(p-sulfophenyl)theophylline on the anticonvulsive action of diphenylhydantoin, phenobarbital, and valproate against maximal electroshock-induced convulsions in mice. J Neural Transm Gen Sect 1993;93:157-63
   PubMed Web of Science ®Google Scholar
• Wlaz P, Rolinski Z, Kleinrok Z, Czuczwar SJ. Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline. J Neural Transm Gen Sect 1992;89:41-8
   PubMed Web of Science ®Google Scholar
• Wlaz P, Rolinski Z, Kleinrok Z, Czuczwar SJ. Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice. Epilepsia 1993;34:385-9
   PubMed Web of Science ®Google Scholar
• Wlaz P, Rolinski Z, Kleinrok Z, Czuczwar SJ. Influence of chronic aminophylline on antielectroshock activity of diazepam and aminophylline-induced convulsions in mice. Pharmacol Biochem Behav 1994;49:609-13
   PubMed Web of Science ®Google Scholar
• Chakrabarti A. A comparative study of aminophylline and acepifylline on reversal phenomenon of anticonvulsant drug efficacy in electroshock model of seizures in rats. Boll Chim Farm 2000;139:270-5
   PubMedGoogle Scholar
• Luszczki JJ, Jankiewicz K, Jankiewicz M, Czuczwar SJ. Pharmacokinetic and pharmacodynamic interactions of aminophylline and topiramate in the mouse maximal electroskock-induced seizure model. Eur J Pharmacol 2007;562:53-9
   PubMed Web of Science ®Google Scholar
• Luszczki JJ, Jankiewicz K, Jankiewicz M, Czuczwar SJ. Influence of aminophylline on the anticonvulsive action of gabapentin in the mouse maximal electroshock seizure threshold model. J Neural Transm 2007;114:1539-45
   PubMed Web of Science ®Google Scholar
• Tutka P, Turski WA, Kleinrok Z, Czuczwar SJ. Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice. J Neural Transm 1996;103:307-14
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Swiader M, Zgrajka W, et al. Influence of several convulsants on the protective activity of a non-competitive AMPA/kainite antagonist, LY 300164, and lamotrigine against maximal electroshock in mice. J Physiol Pharmacol 2002;53:859-69
   PubMed Web of Science ®Google Scholar
• Georgiev V, Johansson B, Fredholm BB. Long term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res 1993;612:271-7
   PubMed Web of Science ®Google Scholar
• Sanders RC, Murray TF. Temporal relationship between A1 adenosine receptor upregulation and alterations in bicuculline seizure susceptibility in rats. Neurosci Lett 1989;101:325-30
   PubMed Web of Science ®Google Scholar
• Von Lubitz DK, Paul IA, Ji XD, et al. Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol 1994;253:95-9
   PubMed Web of Science ®Google Scholar
• Dragunow M. Adenosine receptor antagonism accounts for the seizure-prolonging effects of aminophylline. Pharmacol Biochem Behav 1990;36:751-5
   PubMed Web of Science ®Google Scholar
• Turski WA, Cavalheiro EA, Ikonomidou C. Effects of aminophylline and 2-chloroadenosine on seizures produced by pilocarpine in rats: morphological and electroencephalographic correlates. Brain Res 1985;361:309-23
   PubMed Web of Science ®Google Scholar
• Chwalczuk K, Rubaj A, Swiader M, Czuczwar SJ. Influence of the antagonist of adenosine A1 receptors, 8-cyclopentyl-1,3-dipropylxanthine, upon the anticonvulsant activity of antiepileptic drugs in mice. Przegl Lek 2008;65:759-63; in Polish
   PubMedGoogle Scholar
• Samsonsen C, Brathen G, Reimers A, et al. Is dietary caffeine involved in seizure precipitation? Epilepsy Behav 2013;28:147-50
   PubMed Web of Science ®Google Scholar
• Błaszczyk B. Caffeine and management of epilepsy-a clinical evidence. Pharmacol Rep 2007;59:116
   Web of Science ®Google Scholar
• Meyer BH, Weis OF, Müller FO. Antagonism of diazepam by aminophylline in healthy volunteers. Anesth Analg 1984;63:900-2
   PubMed Web of Science ®Google Scholar
• Czuczwar M, Kis J, Czuczwar P, et al. Nicotine diminishes anticonvulsant activity of antiepileptic drugs in mice. Pol J Pharmacol 2003;55:799-802
   PubMedGoogle Scholar
• Dworetzky BA, Bromfield FB, Townsend MK, Kand JH. A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: data from the Nurses’Health Study II. Epilepsia 2010;51:198-205
   PubMed Web of Science ®Google Scholar
• Curless R, French JM, James OF, Wynne H. Is caffeine a factor in subjective insomnia of elderly people? Age Ageing 1993;22:41-5
   PubMed Web of Science ®Google Scholar
• Sin CW, Ho JS, Chung JW. Systematic review on the effectiveness of caffeine abstinence on the quality of sleep. J Clin Nurs 2009;18:13-21
   PubMed Web of Science ®Google Scholar
• Matos G, Tufik S, Scorza FA, et al. Sleep and epilepsy: exploring an intriguing relationship with a translational approach. Epilepsy Behav 2013;26:405-9
   PubMed Web of Science ®Google Scholar
• Chou T. Wake up and smell the coffee. Caffeine, coffee, and the medical consequences. West J Med 1992;157:544-53
   PubMedGoogle Scholar